BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SenzaGen - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://senzagen.com
X-WR-CALDESC:Events for SenzaGen
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20240603T080000
DTEND;TZID=Europe/Stockholm:20240606T170000
DTSTAMP:20240521T140249Z
CREATED:20240126T091543Z
LAST-MODIFIED:20240521T140249Z
UID:31906-1717401600-1717693200@senzagen.com
SUMMARY:ESTIV Congress 2024
DESCRIPTION:Come meet us at booth #22 and join our presentations to hear the latest news about GARD® and how the assays are used to fill data gaps for skin sensitizing hazard and quantitative potency assessment.  \nAdditionally\, meet ToxHub\, a SenzaGen Group company\, and benefit from expert toxicology and regulatory advice. \nPresentations and Posters\nOur team will showcase several posters and presentations. Dive into new scientific data and discover exciting projects done in collaboration with industry partners. \nTuesday 09:00-10:30 | Presentation in Session 2b\nProject in collaboration with L’Oreal. “Improved confidence of quantitative sensitizing potency assessment for PoD using GARD®skin Dose-Response”\n\nThursday 11:30-12:45 | Presentation in Session 9a\n“Regulatory approval of medical devices according to MDR using in vitro data from GARD®skin Medical Device for skin sensitization assessment” \nPoster | Presented by ToxHub\n#334 | “Integrated Risk Assessment and Compliance Strategies for Nanomaterials in Medical Devices”
URL:https://senzagen.com/event/estiv-congress-2024/
CATEGORIES:Conference
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2024/01/ESTIV-banner.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20240612T080000
DTEND;TZID=Europe/Stockholm:20240614T170000
DTSTAMP:20240126T094148Z
CREATED:20240126T094148Z
LAST-MODIFIED:20240126T094148Z
UID:31924-1718179200-1718384400@senzagen.com
SUMMARY:ITCASS and ERGECD meeting 2024
DESCRIPTION:Meet us in Liverpool at the the 11th meeting of Immunotoxicology & Chemical Allergy (ITCASS) and the 30th meeting of European Research Group on Experimental Contact Dermatitis (ERGECD).
URL:https://senzagen.com/event/itcass-and-ergecd-meeting-2024/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20240627T160000
DTEND;TZID=Europe/Stockholm:20240627T170000
DTSTAMP:20240613T062934Z
CREATED:20240521T140048Z
LAST-MODIFIED:20240613T062934Z
UID:32293-1719504000-1719507600@senzagen.com
SUMMARY:Webinar: Meta-analysis of GARD® data\, 200+ chemicals
DESCRIPTION:Spotlight on in vitro quantitative assessment of skin sensitizing potency.\nJoin our upcoming webinar to explore the recent advancement in GARD® for quantitative assessment of skin sensitizing potency.  \nThis session will present a meta-analysis of GARD® data covering over 200 chemicals\, including three blinded datasets generated in collaboration with industry partners. \nThese data will demonstrate how GARD® can estimate a Point of Departure (PoD) and be incorporated into downstream strategies for Quantitative Risk Assessment (QRA)\, contributing to the assessment of safe use levels of chemicals. \nYou will learn how the assay can be used to predict LLNA EC3 values\, Human NOELs\, and GHS/CLP classifications (1A or 1B). \nThe webinar will last around 30 minutes\, followed by a live Q&A. If you cannot attend the live event\, make sure to register to get access to the recording. \n \nKey topics\n\nAn introduction to the prediction model\, genomics\, and machine learning technology.\nThe GARD® assay’s performance in predicting PoD for QRA.\nHow the GARD® assay ensures the safe use of ingredients in consumer products.\n\nSpeakers\n \n 
URL:https://senzagen.com/event/webinar-meta-analysis-of-gard-data/
CATEGORIES:Webinar
END:VEVENT
END:VCALENDAR